Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Telix.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Arcus, Arcutis, Axsome, Cincor, Clene, Gilead, Immuneering, Lineage, Nabriva, Panbela, Praxis, Providence, Storm, Zynerba.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Boston Scientific, Edwards, Ikonopedia, Ultrasight.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Arvinas, Biosight, Intrabio, Khondrion, Merck & Co., Morphic, Oculis, Telix, VBI.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Mainstay Medical.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Antengene, Astellas, Azura Ophthalmics, Biontech, Bioxytran, Daiichi Sankyo, Edigene, Geneuro, Horizon, Hutchmed, Innovent Biologics, Innovent Biologics, Kyowa Kirin, MEI, Moderna, Organicell Regenerative Medicine, Pfizer, Reistone, Takeda, Tallac, Visen, Zyua Life Sciences.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biofrontera, Concert, Embarkneuro, Lysogene, Neurona, Plus, TC, Tracon.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cerenovous, Inivata, Natera, Neogenomics.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adaptimmune, Ammax, Belite, Candel, Edigene, Escient, Immunomet, Intensity, MEI, Northwest, Oramed, Truebinding.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cerenovus, Grail.